Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Soc Psychiatry Psychiatr Epidemiol. 2013 Dec 28;49(6):991–999. doi: 10.1007/s00127-013-0808-6

Assessing Outcomes of a Stigma-Reduction Intervention with Venue-based Analysis

Li Li 1, Li-Jung Liang 1, Zunyou Wu 2, Chunqing Lin 1, Jihui Guan 3
PMCID: PMC4031272  NIHMSID: NIHMS552370  PMID: 24374721

Abstract

Purpose

A randomized controlled trial with a matched design was conducted during October 2008 and February 2010, aiming at reducing HIV-related stigma in healthcare settings.

Methods

Forty county hospitals in Fujian and Yunnan provinces of China were matched into pairs and randomized to either an intervention condition or a control condition. Forty-four service providers were randomly selected from each hospital, yielding a sample of 1,760. Intervention outcomes were assessed at baseline, 6 and 12 months based on venue-based pair comparisons. We identified and trained 30 popular opinion leaders (POL) in each intervention hospital among service providers to disseminate stigma reduction messages to their peer providers.

Results

Hospital and participant characteristics were comparable between the intervention and control conditions. Thirteen out of twenty pairs of hospitals showed significant reduction in the stigma outcome measure at the 6-month follow-up assessment. For most hospitals, the intervention effects were maintained at the 12-month follow-up assessment. Among the 13 pair of hospitals which showed intervention effect at 6-months, eight were in Fujian and five were in Yunnan. The non-significant hospitals at 6-month had more beds than significant hospitals. However, the difference did not reach statistical significance.

Conclusions

A matched design and venue-based analysis provide more insight in assessing intervention effects for facility-based intervention trials. The identification of venue-based or hospital characteristics that are associated with intervention efficacy provides additional implications for the adaptation and implementation of future interventions.

Keywords: HIV/AIDS, stigma, intervention, matched design, venue-based

INTRODUCTION

It was estimated that there were 780,000 (620,000 – 940,000) people are living with HIV (PLH) in China by the end of 2011 [1]. As HIV infection has evolved into a chronic disease, more and more PLH require regular medical check-ups and routine care in the Chinese health care systems. Previous studies revealed that Chinese service providers’ stigmatizing attitude and behavior were a key barrier for HIV testing and treatment including refusal of care, sub-optimal services, or breach of confidentiality, and were correlated with providers’ perception of social norms as well as concerns about their occupational safety [25]. Most stigma reduction intervention studies have been conducted at the individual level using strategies such as informational approaches, skill building, counseling/support, and testimonials [6]. Given the fact that stigma is a complex social phenomenon that is influenced by many factors (e.g., public policy, institutional governance, social norms), researchers recommend that an intervention with multiple components be used to achieve the maximum effectiveness in attitude and behavioral changes [710].

A randomized controlled trial was conducted in China to address HIV-related stigma and discrimination in healthcare settings. The intervention included both interpersonal and structural level components, with the aim to reduce HIV-related stigma among providers in the medical community. During the trial development, a design issue emerged as whether to use a simple randomization procedure to appoint the intervention and control groups, or alternatively to form matched pairs of clusters and then to allocate the intervention status randomly to one cluster in each pair [11]. The collaborative research team chose the matched-pair design, which increased the potential of achieving balanced intervention groups, thereby improving the power for detecting intervention effect [12,13].

The matched-pair design is not new to the HIV research and has been used in a number of intervention studies [1416]. However, most reports on efficacy focus on intervention outcomes by comparing overall changes in outcome measures between the two intervention conditions or averaging differences between the two conditions across pairs of venues [1719]. Few randomized controlled trials have studied intervention outcomes at the venue level, thus missing the opportunity to obtain supplementary data. For example, some venue-level factors might be associated with intervention outcomes in the venue, but conventional outcome analysis between intervention conditions will omit the opportunity to investigate such factors. In this study, the randomized control trial with the matched-pair design sowed an overall significant intervention effect and the findings were published [20]. We also observed that the intervention effects were not homogeneous across provinces and across matched-pairs of hospitals. These findings motivated us to further estimate the intervention effect at the matched-pair level, and investigate how the intervention effects differ across provinces and matched-pairs. It was also of interest to learn whether any of hospital-level characteristics were associated with the heterogeneous intervention effects. The study results have potential to inform other facility based intervention studies.

METHODS

Study site

The trial was conducted from October 2008 to February 2010 in Fujian and Yunnan Provinces, China. Yunnan province has one of the highest HIV infection rates in China, with 57,325 cases recorded by the end of 2007 [21]. In Yunnan, HIV transmitted through drug use drastically decreased from 100% in 1989 to 42.5% in 2007, while sexual transmission accounted for 47.4% of total cases [21]. In contrast, the reported number of HIV/AIDS cases in Fujian province was relatively low [22]. Fujian reported 1,387 cumulative HIV cases by the end of 2007, with about two-thirds of the cases spread through unprotected sexual acts [23]. Yunnan and Fujian were included in this trial in order to represent the varied HIV rates and infection routes seen in China.

Hospital sampling and matching

This study employed a cluster randomized controlled study design, stratified by province. Only county-level hospitals were included in the study because they are the most advanced medical centers within easy access of most Chinese residents, and many HIV cases are first detected in county hospitals. With administrative support from the Provincial Health Department, a total of 40 hospitals were randomly selected out of 214 county hospitals in the two provinces (20 hospitals from each province). A matched-pair design was applied to optimize the randomization [24,25]. The 20 hospitals in each province were matched into pairs based on 1) type of hospital (general or specialized); 2) number of beds; 3) number of staff; and 4) reported HIV cases. We also collected information about the provision of antiretroviral (ARV) drugs, the history of occupational exposure, and the availability of HIV post-exposure prophylaxis (PEP) drugs in these hospitals. However, these data were not used as matching criteria. Based on the primary criteria, the two hospitals within each pair were randomized to either intervention or control condition. Repeating this procedure resulted in 10 hospitals assigned to the control condition and 10 hospitals assigned to the intervention in each province. The geographic location of the hospitals was considered to avoid potential contamination.

Participant recruitment

Service providers in each hospital were randomly selected from a publicly available hospital staff roster. Providers who delivered direct services to patients, including doctors, nurses, and lab technicians, were included. The sampling ratio of doctors, nurses, and lab technicians was preset at 50%, 45%, and 5%, respectively, to represent the personnel profiles of the medical staff at the county hospitals. Providers had to be 18 years or older to participate. When approaching participants, trained recruiters fully explained the purpose of the study, procedures, voluntary nature of participation, and potential risks and benefits. Written informed consent was obtained before data collection. Forty-four providers were randomly sampled from each of the 40 selected hospitals, resulting in a total of 1,760 provider participants in the study. The refusal rate was about 3%.

Intervention

The intervention, known as White Coat, Warm Heart (WW), was developed based on the findings from previous studies [2,3,7]. The intervention integrated behavioral and structural level components. At the structural level, both intervention and control hospitals received the same amount of universal precaution supplies (e.g., disposable sharp containers, medical disposable clothes, waterproof aprons, protective goggles, and rubber gloves). This component was based on previous findings showing that limited access to universal precaution supplies and lack of precaution practices were related to stigmatizing attitudes and behaviors [2,26]. The behavioral components of the WW intervention were built upon Diffusion of Innovation theory, which states that new behavioral trends are most efficiently established when a “critical mass” of popular opinion leaders (POLs) adopt and endorse the new trend [27,28]. About 20% of service providers who were respected, trustworthy, and influential among peer providers were identified as POLs, recruited, and trained in two waves in each of the 20 intervention hospitals through gatekeeper recommendations and co-worker nominations. A total of 456 POLs were recruited from the 20 intervention hospitals with informed consent (refusal rate was less than 3%). The average age of POLs was 37.7 years at baseline; 69.3% of the POLs were female and 47.4% were doctors.

The POLs participated in four weekly group sessions over a one-month period and three reunion sessions during the 12 months after the initial training. The sessions, each lasted about 90 minutes, were conducted by well-trained local health educators. The contents of group sessions focused on complying with universal precaution principles, ensuring occupational safety, equal treatment to all patients, reducing stigma towards PLH and at-risk population, improving the provider-patient relationship, and making efforts to improve the medical environment. The WW intervention employed interactive strategies to encourage trainees’ full participation. During the training sessions, POL providers learned and practiced communication skills in diffusing intervention messages to their co-workers and serving as behavior change endorsers during their daily medical practice. The participation rate of the training and reunion activities was higher than 95%. Detailed information about the WW intervention is described elsewhere [20].

Data collection

The study procedure and materials were approved by the Institutional Review Boards (IRB) of the University of California, Los Angeles (UCLA), and the IRB of National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention (NCAIDS/CCDC). Hospital characteristics, including location, number of beds, number of service providers, cumulative number of reported HIV cases, provision of ARV therapy, history of occupational exposure, and accessibility of PEP in the hospital, were obtained from public available records and confirmed with hospital gatekeepers. The intervention efficacy was evaluated at baseline and the 6- and 12-month follow-up assessments. At each assessment, all participating providers completed self-administrated paper/pencil questionnaires in a private room, with a trained interviewer present to make sure that the participants finish the questionnaire independently and to clarify the participants’ questions. The standardized survey took an average of 30 to 45 minutes to complete. Participants were compensated 50 yuan (U.S. $7.70) for each assessment. The assessment was not anonymous since the participants were followed up over multiple time points. However, the responses were kept strict confidential. The follow-up rate was higher than 99% across all study sites, and no significant difference was observed in attrition rates between the two intervention conditions (Fig. 1).

Figure 1.

Figure 1

Flow of the participants and venues used in the study.

Providers’ general stigmatizing attitude toward PLH was measured using an eight-item scale that was modified from a scale previously used and validated by our study team in China [2,29]. The statements used in this scale include “People who got HIV/AIDS through sex or drug use got what they deserved” “AIDS is a punishment for bad behavior” “People who behave badly should be blamed for the epidemic of AIDS” “PLH should have the right to marry” “I would feel ashamed if someone I know got HIV/AIDS” “I would feel ashamed if someone in my family got HIV/AIDS” “I would not buy food from a vendor who has HIV/AIDS” “I would not share eating utensils with a PLH.” The responses to each statement ranged from 1 (strongly agree) to 5 (strongly disagree). Some items were reverse coded so that a higher score indicates more severe stigmatizing attitude toward PLH (α = 0.75; range: 8–40). Demographic variables, including age, gender, professional category (doctor, nurse, or lab technician), and if ever had contact with PLH at work (yes or no), were also collected at baseline.

Statistical analysis

An intent-to-treat approach was used to analyze the intervention effects. Baseline differences between intervention and control conditions were compared for both hospital and provider characteristics by province and tested using Chi-square and t tests for categorical and continuous variables, respectively. A mixed-effects regression model that included the providers’ characteristics (age, gender, occupation, whether a provider had prior contact with PLH), hospital indicator, visit (baseline, 6- and 12-month), and hospital-by-visit interaction was used to assess the hospital-level and province-level intervention effects on stigmatizing attitudes through contrasts. The model included a provider-level random effect to account for repeated observations within each provider and a separate set of covariance parameters per province. This modeling approach allows us to estimate not only the intervention effect for each matched pair of hospitals (control vs. intervention), and also the province-level intervention effect by averaging the intervention effects across the matched pairs within the same province through the model contrast. Differences in reducing stigmatizing attitudes (with 95% confidence intervals), adjusting for the provider’s characteristics, between intervention and control were estimated for each pair at both 6- and 12-month follow-ups. All statistical analyses were carried out with the SAS System for Windows (Version 9.2) and all of the graphs were generated using the publicly available statistical software R (R Development Core Team, 2008).

RESUTLS

Hospital and service provider characteristics at baseline

Hospital characteristics and provider sample characteristics are presented in Table 1. The number of beds and providers were comparable between intervention and control hospitals at baseline. The hospitals in Yunnan had reported more HIV cases and occupational exposure accidents than the hospitals in Fujian. More hospitals in Yunnan had provided ARV and had PEP drugs available at baseline than those in Fujian. Approximately 73% of the service providers in Yunnan and 62% in Fujian were female. The average age of participants in Yunnan (38.0 years) and in Fujian (38.2 years) was comparable. However, in Fujian Province, more providers in the control group fell into the younger category (35 years or younger) than the intervention group. About half (48.3% in Yunnan and 50.1% in Fujian) of the participants were doctors. Twice as many (76.0%) providers in Yunnan reported previous contact with PLH. Stratified by province, there was no significant difference in gender, profession, or previous contact with PLH detected between the intervention and control group participants (Table 1).

Table 1.

Hospital characteristics by intervention condition at baseline

Yunnan Fujian

Control N (%) Intervention N (%) P1 Control N (%) Intervention N (%) P1
Hospital characteristics
Number of Hospitals 10 10 10 10
Number of beds
 200 or less 5 (50%) 7 (70%) 0.6499 4 (40%) 2 (20%) 0.6999
 201–500 5 (50%) 3 (30%) 5 (50%) 6 (60%)
 > 500 0 0 1 (10%) 2 (20%)
Number of service providers
 100 or less 1 (10%) 1 (10%) 1.0000 1 (10%) 1 (10%) 0.8000
 101–200 5 (50%) 6 (60%) 2 (20%) 0 (0%)
 201–300 3 (30%) 3 (30%) 2 (20%) 3 (30%)
 >300 1 (10%) 1 (10%) 5 (50%) 6 (60%)
Cumulative number of reported HIV
 None 5 (50%) 5 (50%) 1.0000 4 (40%) 4 (40%) 0.1789
 1–10 3 (30%) 4 (40%) 3 (30%) 6 (60%)
 > 10 2 (20%) 1 (10%) 3 (30%) 0
Currently provide ART service 8 (80%) 7 (70%) 1.0000 1 (10%) 0 1.0000
Occupational exposure accidents in history 3 (30%) 1 (10%) 0.5820 0 0 1.0000
Currently have access to post-exposure prophylaxis 10 10 1.0000 1 (10%) 3 (30%) 0.5820

Service Provider characteristics
Number of Providers 440 440 440 440
Gender
 Female 332 (75.5%) 311 (70.7%) 0.1105 279 (63.4%) 266 (60.5%) 0.3668
Age (Year)
 Mean (SD) 38.2 (7.5) 37.8 (7.6) 0.53252 39.3 (89.9) 37.0 (8.7) 0.59522
 35 or younger 163 (37.1%) 176 (40.0%) 254 (57.7%) 200 (45.5%)
 36–45 198 (45.0%) 181 (41.1%) 118 (26.8%) 149 (33.9%)
 46 or older 79 (18.0%) 83 (18.9%) 68 (15.5%) 91 (20.7%)
Profession
 Doctor 206 (46.8%) 219 (49.8%) 0.5650 218 (49.6%) 223 (50.7%) 0.9386
 Nurse 202 (45.9%) 195 (44.3%) 181 (41.1%) 176 (40.0%)
 Technician/Other 32 (7.3%) 26 (5.9%) 41 (9.3%) 41 (9.3%)
Ever had contact with PLH at work 339 (77.1%) 330 (75.0%) 0.4773 171 (38.9%) 164 (37.4%) 0.6457
1

Chi-square or Fisher exact test;

2

Two-group t-test.

Province-level intervention effects

Table 2 presents the results from the mixed-effects regression and the estimated province-level intervention effects. Providers who had prior contacts with PLH were significantly associated with a lower level of stigmatizing attitudes (P = 0.0054). The hospital-by-visit interaction was significant (P < 0.0001), meaning that the time trends of the stigmatizing attitudes among pairs were different, which can be seen in Figure 2. At 6 months, the estimated differences in alleviation of stigmatizing attitudes between the intervention and control condition were highly significantly for Fujian (2.95 ± 0.32, P <0.0001) and Yunnan (1.87 ± 0.32, P <0.0001). The differences in intervention outcome became larger between these two provinces at 12 months (5.36 vs. 2.20, respectively). Lastly, we estimated the clustering effect using an intra-class correlation (ICC) measure, which can be interpreted as the fraction of total variability explained by hospital-level clustering. We found almost 50% of the total variability was due to the hospital-level variation in Fujian (ICC=0.424) and in Yunnan (ICC=0.489).

Table 2.

Regression estimates of provider’s characteristics and intervention effects from mixed-effects regression model.

Parameter Estimate SE P
Service Provider Characteristics
 Age (in year) −0.001 0.002 0.5201
 Male gender −0.326 0.167 0.0511
 Doctor (vs. nurse/technician/other) 0.104 0.151 0.4911
 Contact HIV −0.389 0.139 0.0054
Tests of Main effects (F statistics)
 Hospital (F[39,1720]=6.44) <.0001
 Visit (F[2,3424]=309.5) <.0001
 Hospital x Visit (F[78,3424]=6.44) <.0001
Intervention Effects1 (by Province)
 Fujian
  6-Month Assessment 2.950 0.316 <.0001
  12-Month Assessment 5.360 0.312 <.0001
 Yunnan
  6-Month Assessment 1.862 0.316 <.0001
  12-Month Assessment 2.196 0.312 <.0001
1

Intervention effect was defined as the difference in reduction of perceived stigma between intervention and control. The intervention effects by province were estimated through model contrasts.

Figure 2.

Figure 2

Estimated difference in stigma reduction (with 95% CI) at 6-month (left) and 12-month (right) follow-up assessments.

The solid circle and the circle with plus symbol represent the estimated difference in stigma reduction for the intervention versus the control condition. The horizontal bar represents the 95% CI and the significance is indicated by one star (P < 0.05) or two stars (P < 0.0001).

Hospital-level intervention effects

Figure 2 presents the estimated differences in reducing stigmatizing attitudes (with 95% confidence interval) for each of the 20 pairs of hospitals from the mixed-effects regression model, adjusting for age, gender, occupation, and prior PLH contact experience. The intervention effects were non-homogeneous among the matched pairs of hospitals. First, there were 13 pairs of hospitals that showed significant reduction in stigmatizing attitudes in the intervention versus the control condition at the 6-month follow-up, with the estimated difference in stigma reduction ranging from 2.19 to 5.02. At the 12-month follow-up, there were 16 pairs of hospitals that showed significant intervention effects, with the estimated difference in stigma reduction ranging from 2.11 to 10.33. These intervention effects either became stronger or persisted except for two pairs located in Yunnan (Pair ID: 18 and 19). Second, among 7 pairs of hospitals that did not show significant intervention effects at 6 month, 5 of them showed significant intervention effects in reducing stigmatizing attitudes at 12 months (range: 2.11 to 3.36). Third, there were 2 pairs of hospitals (Pair ID: 8 and 13) that showed significant intervention effects at the 6-month follow-up but did not last at the 12 months. From these analyses, we observed various magnitudes and patterns of the intervention outcome across 20 pairs of hospitals in two provinces and over two follow-up periods.

Hospital characteristics associated with intervention outcome at 6-month follow-up

For exploratory purpose, we grouped the paired hospitals according to their significances at 6 months: 7 non-significant pairs of hospitals and 13 significant pairs of hospitals, and further examined the associations between hospitals characteristics and intervention effect. First, the average number of hospital beds for those hospitals with non-significant intervention effects was slightly larger than those with significant intervention effects (310 vs. 293, respectively; P=0.72). Specifically, the average size for the pairs of hospitals that achieved statistical significant differences was significantly smaller than those that did not achieve statistical significance in Yunnan (178 vs. 275, respectively, P=0.031). Second, we investigated the proportion of providers who had contact with PLH and its relationship with intervention effect. The proportions of providers with prior contact for those significant pairs of hospitals was significantly lower than those non-significant pairs (50.4% vs. 69.5%, respectively, P=0.048). Lastly, the number of HIV cases treated for the significant pairs of hospitals was on average smaller than those non-significant pairs (11.6 vs. 4.6, respectively; P=0.30). These findings, although preliminary, encouraged further investigations on if hospital-level characteristics were associated with the heterogeneous intervention effects across provinces and matched pairs.

DISCUSSION

This study affirmed the overall effectiveness of the WW intervention for HIV-related stigma reduction in healthcare settings [20]. Interventions that address HIV-related stigma at the facility level have the potential to be cost-effective because they can reach large numbers of members, as demonstrated by some HIV risk reduction interventions [30]. In a recent article, Trickett and colleagues (2011) challenged the research designs in randomized controlled trials [31]. One of the drawbacks identified was the difficulty in investigating diversity because of issues related to statistical power and limited resources [31]. Implementation science focuses not only on the effectiveness of interventions, but also on the translation of interventions into routine practice in diverse settings [32,33]. This requires researchers to identify variations across sites even when the overall effects of the intervention may be of central interest.

An important design feature of the intervention trial is that the 40 hospitals were pair-matched prior to random assignment on the basis of variables known to be correlated with HIV-related stigmatizing attitudes in healthcare settings [3436]. In addition to confirming the efficacy of the WW intervention, we also compared the intervention outcomes within each pair as well as across 20 pairs and further explored the characteristics of hospitals that might be associated with intervention outcomes. Based on the findings, researchers can further explore core elements in the implementation process at the facility level and link them to varying levels of intervention effects. To use different approaches to demonstrate evidence of intervention efficacy reflects the complex social processes involved in facility-level interventions.

Our study revealed that there were regional differences in the effects of the WW intervention, with more intervention hospitals in Fujian showing desirable intervention outcomes at 6-month than hospitals in Yunnan. This was in line with our previous findings from a study [37]. In that study, service providers in Fujian, where HIV prevalence was low, reported a lower level of HIV knowledge and a higher level of stigmatizing attitude toward PLH as compared to providers in Yunnan. Another notable finding from the present study is that providers in Yunnan had a much higher rate of contact with PLH than providers in Fujian. Several researchers have shown that increased contact with PLH may decrease stigma and the desire for social distance and restrictions [38,39]. Thus, low HIV prevalence and lack of contact with PLH may partially explain the relatively high degree of stigmatizing attitude among providers in Fujian. This could be the explanation for the earlier intervention effect seen in Fujian (i.e., there was much room for improvement), whereas in Yunnan there may have been a “ceiling effect” (i.e., less room for improvement) [40,41]. This is another example where there is a need to address intervention outcomes at various levels of analysis [42]. Providers’ individual attitudes toward PLH could be associated with the regional prevalence of the HIV epidemic, and the magnitude of the problem might also influence the effects of the intervention as demonstrated in this study.

We also explored the difference in size of the hospital and its relationship with intervention effects. The hospitals which did not show effect at 6-months appeared to be larger than hospitals which showed effect at 6 months, but some of these hospitals eventually showed effect at 12-month. However, the differences varied by province. In Yunnan, the average size of hospital for the pairs of hospitals that achieved statistical significant differences was statistically smaller than those that did not show effects. The possible interpretation is that it might require longer time for intervention messages to be diffused from POLs to their co-workers in larger hospitals. This finding implies that, for the implementation of a POL intervention, the critical mass of POLs should be taken into consideration and the number of opinion leaders should be determined based on the size of the venue. This is consistent to previous findings that the proportion of “adopters” in the network affects the degree of exposure to the message, and will consequently alter the process of message diffusion [43]. It is important to realize that facility-level interventions targeting social norms and personal behavior need to be implemented for sufficient amounts of time to have a sustainable impact in communities.

The study has limitations. The data were collected only from county-level hospitals in the two provinces, so the results might not be generalizable to other levels of hospitals or hospitals in other geographic areas. Also, the outcome measures relied entirely on self-reported data, so issues surrounding recall accuracy and social-desirability bias can be raised. The stigma variable used in this study did not measure all the dimensions that previous literature identified [44, 45]; with the focus on the prejudicial attitude towards PLH, it was still unclear to what extent it actually reflected the behavior change by providers in serving PLH. The number of pairs of hospitals was relatively small even though some of the associations between intervention effect and the hospital level characteristics reached statistical significance. There were some other implementation factors, such as the fidelity of the training and the enthusiasm of the POLs, which might be more important in mediating the intervention outcome, were not measured or controlled. This study, despite these limitations, explored alternative ways to demonstrate intervention efficacy in stigma reduction that can also be applied to HIV intervention studies in other countries and contexts.

Acknowledgments

FUNDING STATEMENT

This work was supported by the National Institute of Mental Health [Grant number R01-MH081778].

Footnotes

CONTRIBUTORSHIP STATEMENT

Li Li and Zunyou Wu oversaw the design and implementation of the trial and the writing of the article. Li-Jung Liang participated in statistical analysis, interpretation of the results, and writing the data analysis and results sections. Chunqing Lin participated in the writing of introduction and discussion sections. Jihui Guan was responsible for study implementation in the field and assisting in the intervention development. All authors contributed to the preparation of the paper and approved the final draft. The corresponding author had full access to all data in the study and final responsibility for preparing and submitting results for publication.

On behalf of all authors, the corresponding author states that there is no conflict of interest.

TRIAL REGISTRATION:

The trial was registered in the Clinical Trials.gov Protocol Registration System (NCT01052415).

References

  • 1.Ministry of Health, People’s Republic of China, Joint United Nations Programme on HIV/AIDS, World Health Organization, Beijing, China. Estimates for the HIV/AIDS Epidemic in China. 2011 Available at http://www.chinaids.org.cn/n1971/n2151/n777994.files/n777993.pdf.
  • 2.Li L, Wu ZY, Wu S, Zhaoc Y, Jia M, Yan Z. HIV-related stigma in health care settings: a survey of service providers in China. AIDS Patient Care STDS. 2007;21:753–62. doi: 10.1089/apc.2006.0219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wu S, Li L, Wu ZY, Liang L, Cao H, Yan Z, et al. A brief HIV stigma reduction intervention for service providers in China. AIDS Patient Care STDS. 2008;22(6):513–520. doi: 10.1089/apc.2007.0198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Li L, Liang LJ, Lin C, Wu Z, Wen Y. Individual attitudes and perceived social norms: Reports on HIV/AIDS-related stigma among service providers in China. Int J Psychol. 2009;44(6):443–50. doi: 10.1080/00207590802644774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zhang L, Chow EP, Zhang J, Jing J, Wilson DP. Describing the Chinese HIV surveillance system and the influences of political structures and social stigma. Open AIDS J. 2012;6:163–8. doi: 10.2174/1874613601206010163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Brown L, Macintyre K, Trujillo L. Interventions to reduce HIV/AIDS stigma: what have we learned? AIDS Educ Prev. 2003;15:49–69. doi: 10.1521/aeap.15.1.49.23844. [DOI] [PubMed] [Google Scholar]
  • 7.Li L, Liang LJ, Wu ZY, Lin C, Wu S. Institutional support for HIV/AIDS care in China: a multilevel analysis. AIDS Care. 2008;20:1190–6. doi: 10.1080/09540120801919394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Logie CH, James L, Tharao W, Loutfy MR. HIV, gender, race, sexual orientation, and sex work: a qualitative study of intersectional stigma experienced by HIV-positive women in Ontario, Canada. PLoS Med. 2011;8:e1001124. doi: 10.1371/journal.pmed.1001124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Yang Y, Zhang KL, Chan KY, Reidpath DD. Institutional and structural forms of HIV-related discrimination in health care: A study set in Beijing. AIDS Care. 2005;17:129–40. doi: 10.1080/09540120500119874. [DOI] [PubMed] [Google Scholar]
  • 10.Young SD, Konda K, Caceres C, Galea J, Sung-Jae L, Salazar X, Coates T. Effect of a community popular opinion leader HIV/STI intervention on stigma in urban, coastal Peru. AIDS Behav. 2011;15(5):930–7. doi: 10.1007/s10461-010-9826-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Martin DC, Diehr P, Perrin EB, Koepsell TD. The effect of matching on the power of randomized community intervention studies. Stat Med. 1993;12(3–4):329–38. doi: 10.1002/sim.4780120315. [DOI] [PubMed] [Google Scholar]
  • 12.Rothman KJ, Greenland S. Matching. 2. Philadelphia, PA: Lippincott-Raven Publishers; 1998. Modern Epidemiology; pp. 147–162. [Google Scholar]
  • 13.Klar N, Donner A. Current and future challenges in the design and analysis of cluster randomization trials. Stat Med. 2001;20(24):3729–40. doi: 10.1002/sim.1115. [DOI] [PubMed] [Google Scholar]
  • 14.Kelly JA, Murphy DA, Sillema KJ, McAuliffe TL, Roffman RA, Solomon LJ, Winett RA, Kalichman SC. Randomized, controlled, community-level HIV-prevention intervention for sexual-risk behavior among homosexual men in US cities. Lancet. 1997;350(9090):1500–5. doi: 10.1016/s0140-6736(97)07439-4. [DOI] [PubMed] [Google Scholar]
  • 15.Hayes RJ, Alexander NDE, Bennett S, Cousens SN. Design and analysis issues in cluster-randomized trials of interventions against infectious diseases. Stat Methods Med Res. 2000;9(2):95–116. doi: 10.1177/096228020000900203. [DOI] [PubMed] [Google Scholar]
  • 16.Jemmott JB, Jemmott LS, O’Leary A, Ngwane Z, Icard LD, Bellamy SL, Jones SF, Landis JR, Heeren GA, Tyler JC, Makiwane MB. School-based randomized controlled trial of an HIV/STD risk-reduction intervention for South African adolescents. Arch Pediatr Adolesc Med. 2010;164(10):923–9. doi: 10.1001/archpediatrics.2010.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sikkema KJ, Kelly JA, Winett RA, Solomon LJ, Cargill VA, Roffman RA, McAuliffe TL, Heckman TG, Anderson EA, Wagstaff DA, Norman AD, Perry MJ, Crumble DA, Mercer MB. Outcomes of a randomized community-level HIV prevention intervention for women living in 18 low-income housing developments. Am J Public Health. 2000;90(1):57–63. doi: 10.2105/ajph.90.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.The NIMH Collaborative HIV/STD Prevention Trial Group. Results of the NIMH collaborative HIV/sexually transmitted disease prevention trial of a community popular opinion leader intervention. J Acquir Immune Defic Syndr. 2010;54:204–14. doi: 10.1097/QAI.0b013e3181d61def. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rotheram-Borus MJ, Wu Z, Liang LJ, Li L, Detels R, Guan J, Yin Y, Swendeman D NIMH Collaborative HIV/STD Prevention Trial Group et al. Reductions in sexually transmitted infections associated with popular opinion leaders in China in a randomized controlled trial. Sex Transm Infect. 2011;87(4):337–43. doi: 10.1136/sti.2010.046243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Li L, Wu Z, Liang L, Lin C, Guan J, Jia M, Rou K, Yan Z. Reducing HIV-related stigma in health care settings: A randomized controlled trial in China. Am J Public Health. 2012;103(2):286–92. doi: 10.2105/AJPH.2012.300854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jia M, Luo H, Ma Y, Wang N, Smith K, Mei J, Lu R, Lu J, Fu L, Zhang Q, Wu Z, Lu L. The HIV Epidemic in Yunnan Province, China, 1989–2007. J Acquir Immune Defic Syndr. 2010;53(Suppl 1):S34–40. doi: 10.1097/QAI.0b013e3181c7d6ff. [DOI] [PubMed] [Google Scholar]
  • 22.State council AIDS working committee office, UN Theme Group on AIDS in China. A joint assessment of HIV/AIDS Prevention, treatment and care in China. Beijing, China: 2007. [Google Scholar]
  • 23.Southeast Express. [11 June 2012, date last accessed];Fujian HIV reported cases increased 40% on the same period last year, mainly concentrated in Fuzhou, Xiamen and Quanzhou. http://www.dnkb.com.cn/archive/info/20091126/064238585.html.
  • 24.Diehr P, Martin DC, Koepsell T, Cheadle A. Breaking the matches in a paired t-test for community interventions when the number of pairs is small. Stat Med. 1995;14(13):1491–504. doi: 10.1002/sim.4780141309. [DOI] [PubMed] [Google Scholar]
  • 25.Gail MH, Mark SD, Carroll RJ, Green SB, Pee D. On design considerations and randomization-based inference for community intervention trials. Stat Med. 1996;15(11):1069–92. doi: 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  • 26.Wu S, Li L, Wu ZY, Cao H, Lin C, Yan Z, Jia M, Cui H. Universal precautions in the era of HIV/AIDS: perception of health service providers in Yunnan, China. AIDS Behav. 2008;12(5):806–14. doi: 10.1007/s10461-007-9278-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Rogers EM. Diffusion of Innovations. 3. New York, NY: The Free Press; 1983. [Google Scholar]
  • 28.Kelly JA, St Lawrence JS, Diaz YE, Stevenson LY, Hauth AC, Brasfield TL, Kalichman SC, Smith JE, Andrew ME. HIV risk behavior reduction following intervention with key opinion leaders of a population: An experimental community level analysis. Am J Public Health. 1991;81(2):168–71. doi: 10.2105/ajph.81.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Stein JA, Li L. Measuring HIV-related stigma among Chinese service providers: Confirmatory factor analysis of a multidimensional scale. AIDS Behav. 2008;12(5):789–795. doi: 10.1007/s10461-007-9339-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kelly JA. Community-level interventions are needed to prevent new HIV infections. Am J Public Health. 1999;89:299–301. doi: 10.2105/ajph.89.3.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Trickett EJ, Beehler S, Deutsch C, Green LW, Hawe P, McLeroy K, Miller RL, Rapkin BD, Schensul JJ, Schulz AJ, Trimble JE. Advancing the science of community-level interventions. Am J Public Health. 2011;101(8):1410–9. doi: 10.2105/AJPH.2010.300113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Madon T, Hofman KJ, Kupfer L, Glass RI. Public health. Implementation science. Science. 2007;318:1728–9. doi: 10.1126/science.1150009. [DOI] [PubMed] [Google Scholar]
  • 33.Padian NS, Holmes CB, McCoy SI, Lyerla R, Bouey PD, Goosby EP. Implementation science of the US President’s Emergency Plan for AIDS Relief (PEPFAR) J Acquir Immune Defic Syndr. 2011;56(3):199–203. doi: 10.1097/QAI.0b013e31820bb448. [DOI] [PubMed] [Google Scholar]
  • 34.Chan KY, Rungpueng A, Reidpath DD. AIDS and the stigma of sexual promiscuity: Thai nurses’ risk perceptions of occupational exposure to HIV. Cult Health Sex. 2009;11:353–68. doi: 10.1080/13691050802621161. [DOI] [PubMed] [Google Scholar]
  • 35.Genberg BL, Hlavka Z, Konda KA, Maman S, Chariyalertsak S, Chingono A, Mbwambo J, Modiba P, Van Rooyen H, Celentano DD. A comparison of HIV/AIDS-related stigma in four countries: negative attitudes and perceived acts of discrimination towards people living with HIV/AIDS. Soc Sci Med. 2009;68(12):2279–87. doi: 10.1016/j.socscimed.2009.04.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lin C, Li L, Wu Z, Wu S, Jia M. Occupational exposure to HIV among health care providers: A qualitative study in Yunnan, China. J Int Assoc Physicians AIDS Care. 2008;7:35–41. doi: 10.1177/1545109707302089. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Li L, Lin C, Wu Z, Scott Comulada W, Ding Y. Regional differences in HIV prevalence and individual attitudes among service providers. Soc Sci Med. 2012;75(2):283–7. doi: 10.1016/j.socscimed.2012.02.054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Covarrubias I, Han M. Mental health stigma about serious mental illness among MSW students: social contact and attitude. Soc Work. 2011;56(4):317–25. doi: 10.1093/sw/56.4.317. [DOI] [PubMed] [Google Scholar]
  • 39.Yoshii H, Watanabe Y, Kitamura H, Nan Z, Akazawa K. Stigma toward schizophrenia among parents of junior and senior high school students in Japan. BMC Res Notes. 2011;4:558. doi: 10.1186/1756-0500-4-558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.DiClemente RJ, Wingood GM. A randomized controlled trial of an HIV sexual risk-reduction intervention for young African-American women. JAMA. 1995;274(16):1271–6. [PubMed] [Google Scholar]
  • 41.Eccles M, Grimshaw J, Campbell M, Ramsay C. Research designs for studies evaluating the effectiveness of change and improvement strategies. Qual Saf Health Care. 2003;12(1):47–52. doi: 10.1136/qhc.12.1.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Waldo CR, Coates TJ. Multiple levels of analysis and intervention in HIV prevention science: exemplars and directions for new research. AIDS. 2000;14(Suppl 2):S18–S26. [PubMed] [Google Scholar]
  • 43.Valente TW. Social network thresholds in the diffusion of innovations. Social Networks. 1996;18(1):69–89. [Google Scholar]
  • 44.Herek GM. AIDS and stigma. American Behavioral Scientist. 1999;42(7):1106–16. [Google Scholar]
  • 45.Steward WT, Herek GM, Ramakrishna J, Bharat S, Chandy S, Wrubel J, Ekstrand ML. HIV-related stigma: adapting a theoretical framework for use in India. Social Science & Medicine. 2008;67:1225–35. doi: 10.1016/j.socscimed.2008.05.032. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES